184 related articles for article (PubMed ID: 26415657)
21. Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
Kajita D; Nakamura M; Matsumoto Y; Makishima M; Hashimoto Y
Bioorg Med Chem; 2014 Apr; 22(7):2244-52. PubMed ID: 24630694
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
23. Steroid sulfatase inhibitors.
Nussbaumer P; Billich A
Med Res Rev; 2004 Jul; 24(4):529-76. PubMed ID: 15170594
[TBL] [Abstract][Full Text] [Related]
24. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
25. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
26. Structure based design, synthesis, and evaluation of potential inhibitors of steroid sulfatase.
Costa EV; Sousa E; Choosang K; Singh S; Rocha J; Lima RT; Pakkong P; Ahmed S; Vasconcelos MH; Montanari CA; Pinto MM
Curr Top Med Chem; 2014; 14(8):1033-44. PubMed ID: 24660681
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
Moi D; Foster PA; Rimmer LG; Jaffri A; Deplano A; Balboni G; Onnis V; Potter BVL
Eur J Med Chem; 2019 Nov; 182():111614. PubMed ID: 31422224
[TBL] [Abstract][Full Text] [Related]
28. 6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
Schreiner EP; Wolff B; Winiski AP; Billich A
Bioorg Med Chem Lett; 2003 Dec; 13(24):4313-6. PubMed ID: 14643316
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
[TBL] [Abstract][Full Text] [Related]
30. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
31. Recent progress in the development of steroid sulphatase inhibitors - examples of the novel and most promising compounds from the last decade.
Daśko M; Demkowicz S; Biernacki K; Ciupak O; Kozak W; Masłyk M; Rachon J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1163-1184. PubMed ID: 32363947
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.
Woo LW; Wood PM; Bubert C; Thomas MP; Purohit A; Potter BV
ChemMedChem; 2013 May; 8(5):779-99. PubMed ID: 23495205
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
34. Steroid derivatives as inhibitors of steroid sulfatase.
Mostafa YA; Taylor SD
J Steroid Biochem Mol Biol; 2013 Sep; 137():183-98. PubMed ID: 23391659
[TBL] [Abstract][Full Text] [Related]
35. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
Fournier D; Poirier D
Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
[TBL] [Abstract][Full Text] [Related]
36. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
[TBL] [Abstract][Full Text] [Related]
37. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
38. Steroid sulfatase: molecular biology, regulation, and inhibition.
Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
Wang M; Mickens J; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
Steroids; 2009 Nov; 74(12):896-905. PubMed ID: 19559719
[TBL] [Abstract][Full Text] [Related]
40. Lead optimization of 4-(thio)-chromenone 6-
R S; Mk K
J Recept Signal Transduct Res; 2021 Apr; 41(2):123-137. PubMed ID: 32705921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
